Cargando…

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients

BACKGROUND: A higher risk of atherothrombotic cardiovascular events, which are platelet-driven processes, has been described during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). However, the relevance of platelet reactivity during AECOPD and whether this is affected by antip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Esquerre, Mariana, Ferreiro, José Luis, Huertas, Daniel, Marcano, Ana Lucrecia, López-Sánchez, Marta, Roura, Gerard, Gómez-Hospital, Joan Antoni, Dorca, Jordi, Cequier, Angel, Santos, Salud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749392/ https://www.ncbi.nlm.nih.gov/pubmed/29343953 http://dx.doi.org/10.2147/COPD.S152660

Ejemplares similares

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease
por: Muñoz-Esquerre, Mariana, et al.
Publicado: (2016)

Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)
por: Muñoz-Esquerre, Mariana, et al.
Publicado: (2017)

Correction: High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study
por: López-Sánchez, Marta, et al.
Publicado: (2014)

High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study
por: López-Sánchez, Marta, et al.
Publicado: (2013)

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD
por: Aliagas, Elisabet, et al.
Publicado: (2018)

Impact of COVID-19 disease on platelet reactivity and association with inflammatory parameters
por: Ascencio, M, et al.
Publicado: (2021)

Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation
por: Marcano, Ana Lucrecia, et al.
Publicado: (2022)

Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients
por: Careta, Oriol, et al.
Publicado: (2019)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

Clinical Features, Etiology and Outcomes of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Gómez-Junyent, Joan, et al.
Publicado: (2014)

The MGuard coronary stent: safety, efficacy, and clinical utility
por: Gracida, Montserrat, et al.
Publicado: (2015)

Treatment of Slow‐Flow After Primary Percutaneous Coronary Intervention With Flow‐Mediated Hyperemia: The Randomized RAIN‐FLOW Study
por: Gomez‐Lara, Josep, et al.
Publicado: (2023)

Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations
por: Cuevas, Ester, et al.
Publicado: (2023)

Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review
por: Pascual-González, Yuliana, et al.
Publicado: (2018)

Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
por: Lugo, Leslie Marisol, et al.
Publicado: (2020)

Is Platelet Reactivity a Therapeutic Target to Limit Microvascular Obstruction?
por: Carberry, Jaclyn, et al.
Publicado: (2022)

Cost-effectiveness of a European ST-segment elevation myocardial infarction network: results from the Catalan Codi Infart network
por: Regueiro, Ander, et al.
Publicado: (2015)

Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease
por: Lacoma, Alicia, et al.
Publicado: (2011)

Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1
por: Estany, Susanna, et al.
Publicado: (2014)

New Electrocardiographic Algorithm for the Diagnosis of Acute Myocardial Infarction in Patients With Left Bundle Branch Block
por: Di Marco, Andrea, et al.
Publicado: (2020)

Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
por: Jiang, Xiao-Min, et al.
Publicado: (2018)

Radio-Histological Correlation of Lung Features in Severe COVID-19 Through CT-Scan and Lung Ultrasound Evaluation
por: Trias-Sabrià, Pere, et al.
Publicado: (2022)

Effects of hypercapnia on peripheral vascular reactivity in elderly patients with acute exacerbation of chronic obstructive pulmonary disease
por: de Matthaeis, Angela, et al.
Publicado: (2014)

Specific IgA against Pseudomonas aeruginosa in severe COPD
por: Millares, Laura, et al.
Publicado: (2017)

Flavanols and Platelet Reactivity
por: Pearson, Debra A., et al.
Publicado: (2005)

Evaluation of the prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbation of chronic obstructive pulmonary disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2022)

Síndrome de tako-tsubo asociado con COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tako-tsubo syndrome associated with COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19. Respuesta
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19. Response
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Viral etiology of exacerbations of patients with chronic obstructive pulmonary disease during the winter season()
por: Reina, Jordi, et al.
Publicado: (2020)

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease
por: Estirado, Cristina, et al.
Publicado: (2018)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality
por: Casas-Mendez, Fernando, et al.
Publicado: (2018)

Exacerbation of Bronchiectasis
por: Polverino, Eva, et al.
Publicado: (2017)

Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease
por: Geiger-Brown, Jeanne, et al.
Publicado: (2015)

Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2015)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_j4rvrpp78vu9j31ador4s6aupc